We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 9,774 results
  1. Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis

    Purpose

    Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high mortality rate, in which about 90% of patients harbor somatic...

    Tiezhu Shi, **ao Li, ... Linli Yao in Cellular Oncology
    Article 04 April 2023
  2. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition

    Background

    Metastasis of breast cancer have caused the majority of cancer-related death worldwide. The circRNAs are associated with tumorigenesis and...

    Peng Liu, Zehao Wang, ... Hailin Tang in Molecular Cancer
    Article Open access 12 October 2022
  3. High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy

    Background

    Ovarian cancer (OC) is the fifth most common malignant female cancer with a high mortality, mainly because of aggressive high-grade serous...

    Fabio Walther, Jana Ladina Berther, ... Gad Singer in BMC Cancer
    Article Open access 09 April 2022
  4. Soluble factors from TLR4- or TCR-activated cells contribute to stability of the resting phenotype and increase the expression of CXCR4 of human memory CD4 T cells

    It has been proposed that cytokines can induce activation of resting T cells in an antigen-independent manner. However, experimental conditions have...

    Isabel Ruelas-Galindo, Leonor Huerta in Immunologic Research
    Article 21 December 2022
  5. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer

    Background

    Crosstalk between neoplastic and stromal cells fosters prostate cancer (PCa) progression and dissemination. Insight in cell-to-cell...

    Isabel Heidegger, Georgios Fotakis, ... Andreas Pircher in Molecular Cancer
    Article Open access 18 June 2022
  6. Sigma-1 Receptor Alleviates Airway Inflammation and Airway Remodeling Through AMPK/CXCR4 Signal Pathway

    Sigma non-opioid intracellular receptor 1 (Sigma-1R) has been proven to play a major role in inflammation and structural remodeling. However, its...

    Te Jiang, Di Zhao, ... Zhankui Li in Inflammation
    Article 14 January 2022
  7. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment

    Background

    The bone marrow (BM) is the most common site of dissemination in patients with aggressive, metastatic neuroblastoma (NB). However, the...

    Laura Garcia-Gerique, Marta García, ... Cinzia Lavarino in BMC Cancer
    Article Open access 17 June 2022
  8. Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD

    Allogeneic hematopoietic cell transplantation (allo-HCT) is a promising therapeutic option for hematological malignancies, but relapse resulting...

    Long Su, Ming-Hui Fang, ... Yong-Guang Yang in Cellular & Molecular Immunology
    Article 11 October 2021
  9. CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

    The highly restricted expression of B-cell maturation antigen (BCMA) on plasma cells makes it an ideal target for chimeric antigen receptor (CAR)...

    Yu Yang Ng, Zhicheng Du, ... Shu Wang in Cancer Gene Therapy
    Article 01 September 2021
  10. A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism

    We present 109 near full-length HIV genomes amplified from blood serum samples obtained during early 1986 from across Uganda, which to our knowledge...

    Heather E. Grant, Sunando Roy, ... Andrew J. Leigh Brown in Retrovirology
    Article Open access 13 December 2022
  11. SDF-1α/CXCR4 Pathway Mediates Hemodynamics-Induced Formation of Intracranial Aneurysm by Modulating the Phenotypic Transformation of Vascular Smooth Muscle Cells

    The objective of this study is to explore the role of the SDF-1α/CXCR4 pathway in the development of intracranial aneurysm (IA) induced by...

    Yazhou Yan, Jiachao **ong, ... Qinghai Huang in Translational Stroke Research
    Article 25 June 2021
  12. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)

    Background

    The molecular prognostic biomarkers of clear cell renal cell carcinoma (ccRCC) are still unknown. We aimed at researching the candidate...

    **g Quan, Yuchen Bai, ... Dahong Zhang in BMC Cancer
    Article Open access 15 July 2021
  13. Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

    Background

    Endogenous Peptide Inhibitor of CXCR4 (EPI-X4) is a natural antagonist of the CXC chemokine receptor 4 (CXCR4). EPI-X4 is a 16-mer peptide...

    Andrea Gilg, Mirja Harms, ... Jan Münch in Journal of Translational Medicine
    Article Open access 03 May 2021
  14. The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker

    There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer’s and...

    Yudie Yan, **gtong Su, Zhen Zhang in Cellular and Molecular Neurobiology
    Article 12 June 2021
  15. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling

    Background

    Medullary thyroid cancer (MTC) represents 13.4 % of all thyroid cancers-related deaths. The treatments for MTC are very limited especially...

    Xun Zheng, Shu Rui, ... Zhi-Hui Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 07 May 2021
  16. Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma

    Glioblastoma (GBM) are life-threatening tumors with a poor prognosis and low cure rates. GBMs are malignant brain tumors that develop from...

    Zhengxiang Luo, Bin Wang, ... Lei Shi in Pathology & Oncology Research
    Article 06 July 2020
  17. EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson’s Disease Through the CXCL12/CXCR4 Signaling Pathway

    There is increasing evidence that EphA1 is involved in the function and development of the central nervous system, especially in neuroinflammation....

    Jianjun Ma, Zhidong Wang, ... Xue Li in Molecular Neurobiology
    Article 15 October 2020
  18. TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma

    Background

    Long noncoding RNA taurine upregulated 1 (TUG1) has been reported to play an important role in human cancers. However, little is known...

    Ke Zhang, Hong Zhou, ... Xuan** Cao in Cancer Cell International
    Article Open access 06 May 2020
Did you find what you were looking for? Share feedback.